Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

pharmiweb.com today archive

2493 PWToday Stories

Protagen AG successfully joined forces with Novartis to support Clinical Development of a Novel Compound in an Autoimmune Indication

21 Dec 16

PROTAGEN AG, a leading provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology and autoimmune disease, today announced the successful completion a collaboration agreement with Novartis Pharma AG. During the collaboration, Protagen utilized its proprietary SeroTag technology to discover prediction as well as patient stratification markers for a novel drug being developed by Novartis.

Protagen CBO Georg Lautscham commented: “Our innovative SeroTag technology has proven on numerous occasions that it can monitor the immune-health status of patients, thereby allowing for the first time the systematic determination of response prediction and disease as well as patient stratification markers to select the most appropriate drug and therapy in autoimmune indications. This was evaluated in our collaboration with Novartis and we would like to thank Novartis’ R&D team for the excellent, productive and collaborative relationship.”

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.